Millennium Management’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-553,684
| Closed | -$9.73M | – | 6287 |
|
2021
Q3 | $9.73M | Buy |
553,684
+345,612
| +166% | +$6.07M | 0.01% | 1518 |
|
2021
Q2 | $2.02M | Sell |
208,072
-572,686
| -73% | -$5.55M | ﹤0.01% | 3139 |
|
2021
Q1 | $8.39M | Sell |
780,758
-90,566
| -10% | -$973K | 0.01% | 1559 |
|
2020
Q4 | $12.8M | Buy |
871,324
+266,867
| +44% | +$3.93M | 0.01% | 1118 |
|
2020
Q3 | $8.59K | Sell |
604,457
-44,396
| -7% | -$631 | 0.01% | 1056 |
|
2020
Q2 | $5.25M | Sell |
648,853
-1,094,677
| -63% | -$8.86M | 0.01% | 1368 |
|
2020
Q1 | $7.04M | Buy |
+1,743,530
| New | +$7.04M | 0.02% | 851 |
|
2018
Q3 | – | Sell |
-13,704
| Closed | -$82K | – | 3898 |
|
2018
Q2 | $82K | Sell |
13,704
-2,822
| -17% | -$16.9K | ﹤0.01% | 3299 |
|
2018
Q1 | $119K | Buy |
16,526
+3,926
| +31% | +$28.3K | ﹤0.01% | 3228 |
|
2017
Q4 | $91K | Buy |
12,600
+782
| +7% | +$5.65K | ﹤0.01% | 3438 |
|
2017
Q3 | $61K | Buy |
+11,818
| New | +$61K | ﹤0.01% | 3132 |
|
2017
Q2 | – | Sell |
-10,126
| Closed | -$62K | – | 3680 |
|
2017
Q1 | $62K | Sell |
10,126
-4,174
| -29% | -$25.6K | ﹤0.01% | 3135 |
|
2016
Q4 | $81K | Sell |
14,300
-2,910
| -17% | -$16.5K | ﹤0.01% | 3000 |
|
2016
Q3 | $254K | Sell |
17,210
-97,286
| -85% | -$1.44M | ﹤0.01% | 2644 |
|
2016
Q2 | $1.03M | Sell |
114,496
-139,702
| -55% | -$1.25M | ﹤0.01% | 1942 |
|
2016
Q1 | $2.35M | Buy |
254,198
+23,013
| +10% | +$213K | 0.01% | 1538 |
|
2015
Q4 | $2.92M | Buy |
231,185
+70,072
| +43% | +$884K | 0.01% | 1565 |
|
2015
Q3 | $2.1M | Buy |
161,113
+22,660
| +16% | +$295K | ﹤0.01% | 1719 |
|
2015
Q2 | $3.02M | Buy |
+138,453
| New | +$3.02M | 0.01% | 1547 |
|